Diagnostic stewardship > antibiotic stewardship for ASB.
There's likely value in work at any stage along the pathway above, but appears preventing the UCx from happening in the first place is the best bang for your buck.
Next up is Dr. Will Allegria to talk about stewardship in Immunocompromised patients.
This is a complicated patient population.
#SHEASpring2024
1/
Many challenges in this patient population, with limited guidelines and data.
Note the specialists (hematology, oncology, transplant) unique to this setting that should be part of the stewardship team. Definitely include transplant ID docs when you have them
Bookmark this thread folks, some great stuff below.
First up is Dr. Jim Lewis.
#SHEASpring2024
1/
First up is busting the "cidal vs static" myth. Jim says he is "quoting Noah to Noah" with @IDwithNWD standing by for the next talk, and an author on this excellent paper with @BradSpellberg.
56 Trials!
#SHEASpring2024
2/
What about MRSA pneumonia?
Linezolid and Vancomycin on equal footing.
The "cidal" definition is completely arbitrary, lab based, and irrelevant clinically.
With a Geriatric audience, had to take the opportunity to focus first on the urine.
But also get into SSTI, Bactrim for Group A strep, if you need IV antibiotics for Lyme, dental prophylaxis for prosthetic joints, and duration of therapy.
First up - does +UA/UCx=UTI?
2/
Emphatic NO on that one.
Need SYMPTOMS to diagnose a UTI.
I tell patients they need to tell us, we can't tell them.
Positive UCx without symptoms = asymptomatic bacteriuria.